Category Archives: Corporate

Sackler Family, Purdue Pharma not the only ones to blame for US opiod crisis. Not by a long shot.

The News: After months of negotiations and threats, Purdue Pharma LP (Stamford CT) finally filed for bankruptcy earlier this week. But it’s hardly a done deal, according to The New York Times…. Read more »

Health-sector IPO action heating up big time after Labor Day pause.

Health-sector initial public offerings are alive and kicking again, as over $1B was raised last week among just for aspiring players, now taking their chances in the big league stock… Read more »

Health-sector stocks mostly up after nerve-racking presidential debate.

Winners barely beat out losers last week as health care outshone climate change and gun control (among other topics) at the latest Democratic debate last week. (See our broader health-sector… Read more »

All three of the world’s major drug regulators have busy week despite heat waves, political chaos. You know; the usual.

Last week was a rare case where the world’s leading drugs and devices regulators were all in action simultaneously. The US Food and Drug Administration (FDA), the European Medicines Agency… Read more »

Pace of health-sector IPO action finally slows, but deal sizes grow, proving lots of cash still parked on the sidelines.

Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »

July’s IPO action in health sector foreshadows record month of pricings.

The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »

BioNTech raises $325M in Series B round, skipping IPO for now

The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where does German biotech stand vis-à-vis the… Read more »